Abstract
We sought to evaluate the delays, between-centre variations in practice, and opportunity costs attributable to delays in research governance approval of clinical trials in the United Kingdom.
| Original language | English |
|---|---|
| Pages (from-to) | 101-4 |
| Number of pages | 4 |
| Journal | Journal of the Royal Society of Medicine |
| Volume | 100 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2007 |
Keywords / Materials (for Non-textual outputs)
- Biomedical Research
- Costs and Cost Analysis
- Humans
- Multicenter Studies as Topic
- Organizational Policy
- Randomized Controlled Trials as Topic
- Retrospective Studies
Fingerprint
Dive into the research topics of 'Research governance impediments to clinical trials: a retrospective survey'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver